US tariffs on patented drugs won’t hit Indian pharma immediately, says Bhaskar Chakravorti, but future risk to generics remains. He urged India to cut Russian oil imports as a signal to Washington.

Washington : Bhaskar Chakravorti, Dean of Global Business at The Fletcher School of Law and Diplomacy at Tufts University, has said that US President Donald Trump’s decision to impose 100 per cent tariffs on pharmaceuticals will not immediately impact India.

In an exclusive interview with IANS, Chakravorti cautioned that the move could be a precursor to future action on Indian generics.

“This specific move to put tariffs on patented pharmaceuticals is not something that is directly going to affect Indian manufacturers as much, but it’s coming awfully close. I wouldn’t rule out tariffs on gen

See Full Page